Biomarin Pharmaceutical Inc Capital Reinvestment Ratio
Biomarin Pharmaceutical Inc capital reinvestment ratio. Biomarin Pharmaceutical Inc (BMRN) has a Capital Reinvestment Ratio of 0.17x as of June 2026, meaning it reinvests 0% of its operating cash flow ($168.11 Million) in capital expenditures ($28.82 Million). Check Biomarin Pharmaceutical Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Biomarin Pharmaceutical Inc (2009–2025)
Capital reinvestment ratio of Biomarin Pharmaceutical Inc from 2009 to 2025. This chart tracks Biomarin Pharmaceutical Inc's Capital Reinvestment Ratio across 12 annual periods. Also explore BMRN net assets growth trend to track the company's year-over-year net asset growth rate.
Biomarin Pharmaceutical Inc Capital Reinvestment Ratio by Year (2009–2025)
Biomarin Pharmaceutical Inc capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see BMRN cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $827.99 Million | $103.04 Million | ▼ -26.8% |
| 2024 | 0.17x | $572.84 Million | $97.42 Million | ▼ -74.8% |
| 2023 | 0.68x | $159.26 Million | $107.61 Million | ▼ -1.7% |
| 2022 | 0.69x | $175.90 Million | $120.96 Million | ▲ +75.6% |
| 2021 | 0.39x | $304.54 Million | $119.22 Million | ▼ -75.7% |
| 2020 | 1.61x | $85.36 Million | $137.52 Million | ▼ -46.4% |
| 2019 | 3.00x | $48.26 Million | $145.03 Million | ▼ -58.0% |
| 2018 | 7.16x | $20.21 Million | $144.62 Million | ▲ +182.7% |
| 2012 | 2.53x | $17.61 Million | $44.57 Million | ▼ -69.2% |
| 2011 | 8.22x | $18.75 Million | $154.22 Million | ▲ +211.7% |
| 2010 | 2.64x | $18.75 Million | $49.46 Million | ▲ +157.8% |
| 2009 | 1.02x | $87.73 Million | $89.80 Million | — |